Results 151 to 160 of about 110,517 (296)
A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
The Stellar Initial Mass Function and Beyond
Presented at the IAOC Workshop on "Galactic Star Formation Across the Stellar Mass Spectrum", La Serena, Chile, March 2002; published in the ASP Conference Series, edited by J. M. De Buizer and N. S. van der Bliek.
openaire +2 more sources
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
We analyzed the global and resolved properties of approximately 1240 nearby star-forming galaxies from the MaNGA survey, comparing compact and extended galaxies—those with smaller and larger radii ( R _e ), respectively—at a fixed stellar mass ( M _ ...
Lin Lin +4 more
doaj +1 more source
Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source
We build upon FEGA25 , a previously introduced semianalytic model (SAM) for galaxy formation and evolution, by focusing on its enhanced treatment of supernova (SN) and active galactic nucleus (AGN) feedback mechanisms.
Emanuele Contini +4 more
doaj +1 more source
Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla +10 more
wiley +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Quadratic Frequency Dispersion in the Oscillations of Intermediate-mass Stars
Asteroseismology, the study of stellar vibration, has met with great success, shedding light on stellar interior structure, rotation, and magnetism. Prominently known as δ Scutis, the intermediate-mass main-sequence oscillators that often exhibit rapid ...
Subrata Kumar Panda +3 more
doaj +1 more source

